Investment House LLC Indaptus Therapeutics, Inc. Call Options Transaction History

Investment House LLC

  • $1.9 Billion
  • Q2 2025

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

Others Institutions Holding INDP

# of Institutions
2
Shares Held
43.9K
Call Options Held
0
Put Options Held
0
View Full List

About Indaptus Therapeutics, Inc.

INDP Quotes by TradingView
  • Ticker INDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,258,600
  • Market Cap $68.1M
  • Description
  • Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...
More about INDP
Track This Portfolio

Track Investment House LLC Portfolio

Follow Investment House LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment House LLC, based on Form 13F filings with the SEC.

News

Stay updated on Investment House LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email